200 related articles for article (PubMed ID: 18385520)
41. Inactivation of TGF-beta signaling in hepatocytes results in an increased proliferative response after partial hepatectomy.
Romero-Gallo J; Sozmen EG; Chytil A; Russell WE; Whitehead R; Parks WT; Holdren MS; Her MF; Gautam S; Magnuson M; Moses HL; Grady WM
Oncogene; 2005 Apr; 24(18):3028-41. PubMed ID: 15735717
[TBL] [Abstract][Full Text] [Related]
42. Invasion of retinal pigment epithelial cells: N-cadherin, hepatocyte growth factor, and focal adhesion kinase.
Van Aken EH; De Wever O; Van Hoorde L; Bruyneel E; De Laey JJ; Mareel MM
Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):463-72. PubMed ID: 12556370
[TBL] [Abstract][Full Text] [Related]
43. Cellular and molecular mechanisms of HGF/Met in the cardiovascular system.
Gallo S; Sala V; Gatti S; Crepaldi T
Clin Sci (Lond); 2015 Dec; 129(12):1173-93. PubMed ID: 26561593
[TBL] [Abstract][Full Text] [Related]
44. Hepatocyte growth factor transforms immortalized mouse liver epithelial cells.
Kanda H; Tajima H; Lee GH; Nomura K; Ohtake K; Matsumoto K; Nakamura T; Kitagawa T
Oncogene; 1993 Nov; 8(11):3047-53. PubMed ID: 8414505
[TBL] [Abstract][Full Text] [Related]
45. HGF: a multifunctional growth factor controlling cell scattering.
Stella MC; Comoglio PM
Int J Biochem Cell Biol; 1999 Dec; 31(12):1357-62. PubMed ID: 10641789
[TBL] [Abstract][Full Text] [Related]
46. Hepatocyte-specific c-Met deletion disrupts redox homeostasis and sensitizes to Fas-mediated apoptosis.
Gómez-Quiroz LE; Factor VM; Kaposi-Novak P; Coulouarn C; Conner EA; Thorgeirsson SS
J Biol Chem; 2008 May; 283(21):14581-9. PubMed ID: 18348981
[TBL] [Abstract][Full Text] [Related]
47. HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice.
Weimar IS; Weijer K; van den Berk PC; Muller EJ; Miranda N; Bakker AQ; Heemskerk MH; Hekman A; de Gast GC; Gerritsen WR
Br J Cancer; 1999 Sep; 81(1):43-53. PubMed ID: 10487611
[TBL] [Abstract][Full Text] [Related]
48. Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists.
Michieli P; Basilico C; Pennacchietti S; Maffè A; Tamagnone L; Giordano S; Bardelli A; Comoglio PM
Oncogene; 1999 Sep; 18(37):5221-31. PubMed ID: 10498872
[TBL] [Abstract][Full Text] [Related]
49. Extracellular signal-regulated kinase and Akt activation play a critical role in the process of hepatocyte growth factor-induced epithelial-mesenchymal transition.
Tanahashi T; Osada S; Yamada A; Kato J; Yawata K; Mori R; Imai H; Sasaki Y; Saito S; Tanaka Y; Nonaka K; Yoshida K
Int J Oncol; 2013 Feb; 42(2):556-64. PubMed ID: 23229794
[TBL] [Abstract][Full Text] [Related]
50. Hepatocyte growth factor enhances death receptor-induced apoptosis by up-regulating DR5.
Li Y; Fan X; Goodwin CR; Laterra J; Xia S
BMC Cancer; 2008 Nov; 8():325. PubMed ID: 18992144
[TBL] [Abstract][Full Text] [Related]
51. A selective c-met inhibitor blocks an autocrine hepatocyte growth factor growth loop in ANBL-6 cells and prevents migration and adhesion of myeloma cells.
Hov H; Holt RU; Rø TB; Fagerli UM; Hjorth-Hansen H; Baykov V; Christensen JG; Waage A; Sundan A; Børset M
Clin Cancer Res; 2004 Oct; 10(19):6686-94. PubMed ID: 15475459
[TBL] [Abstract][Full Text] [Related]
52. Hepatocyte growth factor exerts multiple biological functions on bovine mammary epithelial cells.
Accornero P; Martignani E; Macchi E; Baratta M
J Dairy Sci; 2007 Sep; 90(9):4289-96. PubMed ID: 17699048
[TBL] [Abstract][Full Text] [Related]
53. Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in mice.
Kroy DC; Schumacher F; Ramadori P; Hatting M; Bergheim I; Gassler N; Boekschoten MV; Müller M; Streetz KL; Trautwein C
J Hepatol; 2014 Oct; 61(4):883-90. PubMed ID: 24845607
[TBL] [Abstract][Full Text] [Related]
54. Transforming growth factor-beta differentially regulates oval cell and hepatocyte proliferation.
Nguyen LN; Furuya MH; Wolfraim LA; Nguyen AP; Holdren MS; Campbell JS; Knight B; Yeoh GC; Fausto N; Parks WT
Hepatology; 2007 Jan; 45(1):31-41. PubMed ID: 17187411
[TBL] [Abstract][Full Text] [Related]
55. Elevated hepatocyte growth factor expression as an autocrine c-Met activation mechanism in acquired resistance to sorafenib in hepatocellular carcinoma cells.
Firtina Karagonlar Z; Koc D; Iscan E; Erdal E; Atabey N
Cancer Sci; 2016 Apr; 107(4):407-16. PubMed ID: 26790028
[TBL] [Abstract][Full Text] [Related]
56. Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.
Maulik G; Kijima T; Ma PC; Ghosh SK; Lin J; Shapiro GI; Schaefer E; Tibaldi E; Johnson BE; Salgia R
Clin Cancer Res; 2002 Feb; 8(2):620-7. PubMed ID: 11839685
[TBL] [Abstract][Full Text] [Related]
57. Contact inhibition of hepatocyte growth regulated by functional association of the c-Met/hepatocyte growth factor receptor and LAR protein-tyrosine phosphatase.
Machide M; Hashigasako A; Matsumoto K; Nakamura T
J Biol Chem; 2006 Mar; 281(13):8765-72. PubMed ID: 16415345
[TBL] [Abstract][Full Text] [Related]
58. Met-HGF/SF signal transduction induces mimp, a novel mitochondrial carrier homologue, which leads to mitochondrial depolarization.
Yerushalmi GM; Leibowitz-Amit R; Shaharabany M; Tsarfaty I
Neoplasia; 2002; 4(6):510-22. PubMed ID: 12407445
[TBL] [Abstract][Full Text] [Related]
59. The hepatocyte growth factor isoform NK2 activates motogenesis and survival but not proliferation due to lack of Akt activation.
Mungunsukh O; Lee YH; Bottaro DP; Day RM
Cell Signal; 2016 Aug; 28(8):1114-23. PubMed ID: 27224506
[TBL] [Abstract][Full Text] [Related]
60. Delayed recanalization after MCAO ameliorates ischemic stroke by inhibiting apoptosis via HGF/c-Met/STAT3/Bcl-2 pathway in rats.
Tang H; Gamdzyk M; Huang L; Gao L; Lenahan C; Kang R; Tang J; Xia Y; Zhang JH
Exp Neurol; 2020 Aug; 330():113359. PubMed ID: 32428505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]